{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:51:05Z","timestamp":1788612665766,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-024-03426-2","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T09:02:54Z","timestamp":1730365374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Infiltrations of plasma cells in synovium predict inadequate response to Adalimumab in Rheumatoid Arthritis patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Jian Bin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"issue":"1","key":"3426_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13075-023-03140-5","volume":"25","author":"Y Shao","year":"2023","unstructured":"Shao Y, Zhang H, Shi Q, et al. Clinical prediction models of rheumatoid arthritis and its complications: focus on cardiovascular disease and interstitial lung disease. Arthritis Res Ther. 2023;25(1):159.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"3426_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000493390","volume":"27","author":"J Bullock","year":"2018","unstructured":"Bullock J, Rizvi SAA, Saleh AM, et al. Rheumatoid arthritis: a brief overview of the treatment. Med Princ Pract. 2018;27(6):501\u20137.","journal-title":"Med Princ Pract"},{"issue":"3","key":"3426_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/17460441.2021.1846516","volume":"16","author":"E Pelechas","year":"2021","unstructured":"Pelechas E, Voulgari PV, Drosos AA. Preclinical discovery and development of adalimumab for the treatment of rheumatoid arthritis. Expert Opin Drug Discov. 2021;16(3):227\u201334.","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"3426_CR4","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1016\/S2665-9913(23)00070-X","volume":"5","author":"H Tamai","year":"2023","unstructured":"Tamai H, Ikeda K, Miyamoto T, et al. Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial. Lancet Rheumatol. 2023;5(4):e215\u201324.","journal-title":"Lancet Rheumatol"},{"key":"3426_CR5","doi-asserted-by":"crossref","unstructured":"Machado MA, Maciel AA, de Lemos LL et al. Adalimumab in rheumatoid arthritis treatment: a systematic review and meta-analysis of randomized clinical trials. Rev Bras Reumatol. 2013 Sep-Oct;53(5):419\u2009\u2013\u200930. English, Portuguese. Erratum in: Rev Bras Reumatol. 2014 Mar-Apr;43(2):160.","DOI":"10.1016\/S2255-5021(13)70113-5"},{"key":"3426_CR6","doi-asserted-by":"publisher","first-page":"1759720X2211141","DOI":"10.1177\/1759720X221114101","volume":"14","author":"PC Taylor","year":"2022","unstructured":"Taylor PC, Matucci Cerinic M, Alten R, et al. Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes. Ther Adv Musculoskelet Dis. 2022;14:1759720X221114101.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"3426_CR7","doi-asserted-by":"publisher","unstructured":"Radner H, Neogi T, Smolen JS, et al. Performance of the 2010 ACR\/EULAR classification criteria for rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2014;73(1):114\u201323. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203284.","DOI":"10.1136\/annrheumdis-2013-203284"},{"issue":"6","key":"3426_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/icb.2013.15","volume":"91","author":"EA Moelants","year":"2013","unstructured":"Moelants EA, Mortier A, Van Damme J, et al. Regulation of TNF-\u03b1 with a focus on rheumatoid arthritis. Immunol Cell Biol. 2013;91(6):393\u2013401.","journal-title":"Immunol Cell Biol"},{"key":"3426_CR9","first-page":"51","volume":"1","author":"C Papagoras","year":"2009","unstructured":"Papagoras C, Voulgari PV, Drosos AA. Long-term use of adalimumab in the treatment of rheumatic diseases. Open Access Rheumatol. 2009;1:51\u201368.","journal-title":"Open Access Rheumatol"},{"key":"3426_CR10","doi-asserted-by":"publisher","first-page":"1759720X2211141","DOI":"10.1177\/1759720X221114101","volume":"14","author":"PC Taylor","year":"2022","unstructured":"Taylor PC, Matucci Cerinic M, et al. Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes. Ther Adv Musculoskelet Dis. 2022;14:1759720X221114101.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"12","key":"3426_CR11","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1007\/s10067-022-06307-8","volume":"41","author":"Y Khader","year":"2022","unstructured":"Khader Y, Beran A, Ghazaleh S, et al. Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis. Clin Rheumatol. 2022;41(12):3615\u201327.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"3426_CR12","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1093\/rheumatology\/keaa877","volume":"60","author":"X Yue","year":"2021","unstructured":"Yue X, Huang B, Hincapie AL, et al. Comparative effectiveness and persistence of TNFi and non-TNFi in juvenile idiopathic arthritis: a large paediatric rheumatology centre in the USA. Rheumatology (Oxford). 2021;60(9):4063\u201373.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3426_CR13","doi-asserted-by":"publisher","first-page":"11876","DOI":"10.1038\/s41598-022-15293-5","volume":"12","author":"U Hardt","year":"2022","unstructured":"Hardt U, Carlberg K, Af Klint E, et al. Integrated single cell and spatial transcriptomics reveal autoreactive differentiated B cells in joints of early rheumatoid arthritis. Sci Rep. 2022;12(1):11876.","journal-title":"Sci Rep"},{"issue":"2","key":"3426_CR14","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1186\/ar4555","volume":"16","author":"G Dennis Jr","year":"2014","unstructured":"Dennis G Jr, Holweg CT, Kummerfeld SK, et al. Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Res Ther. 2014;16(2):R90.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"3426_CR15","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s10067-020-05043-1","volume":"39","author":"J Zhao","year":"2020","unstructured":"Zhao J, Ye X, Zhang Z. The predictive value of serum soluble ICAM-1 and CXCL13 in the therapeutic response to TNF inhibitor in rheumatoid arthritis patients who are refractory to csDMARDs. Clin Rheumatol. 2020;39(9):2573\u201381.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"3426_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1756-185X.2011.01643.x","volume":"14","author":"K Kanbe","year":"2011","unstructured":"Kanbe K, Chiba J, Nakamura A. Decrease of CD68 and MMP-3 expression in synovium by treatment of adalimumab for rheumatoid arthritis. Int J Rheum Dis. 2011;14(3):261\u20136.","journal-title":"Int J Rheum Dis"},{"issue":"10271","key":"3426_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0140-6736(20)32341-2","volume":"397","author":"F Humby","year":"2021","unstructured":"Humby F, Durez P, Buch MH, et al. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet. 2021;397(10271):305\u201317.","journal-title":"Lancet"},{"key":"3426_CR18","unstructured":"Allen HC, Sharma P, Histology PC. [Updated 2022 Dec 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK556082\/"},{"issue":"4","key":"3426_CR19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/imm.13412","volume":"164","author":"U Karmakar","year":"2021","unstructured":"Karmakar U, Vermeren S. Crosstalk between B cells and neutrophils in rheumatoid arthritis. Immunology. 2021;164(4):689\u2013700.","journal-title":"Immunology"},{"issue":"9","key":"3426_CR20","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","volume":"28","author":"MJ Lewis","year":"2019","unstructured":"Lewis MJ, Barnes MR, Blighe K, et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell Rep. 2019;28(9):2455\u2013e24705.","journal-title":"Cell Rep"},{"issue":"5","key":"3426_CR21","doi-asserted-by":"publisher","first-page":"151909","DOI":"10.1016\/j.acthis.2022.151909","volume":"124","author":"P Dolzani","year":"2022","unstructured":"Dolzani P, Manferdini C, Meliconi R, et al. Preliminary study on immune cells in the synovium of end-stage osteoarthritis and rheumatoid arthritis patients: neutrophils and IgG4-secreting plasma cells as differential diagnosis candidates. Acta Histochem. 2022;124(5):151909.","journal-title":"Acta Histochem"},{"issue":"7","key":"3426_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00296-008-0773-7","volume":"29","author":"W Dong","year":"2009","unstructured":"Dong W, Li X, Liu H, et al. Infiltrations of plasma cells in synovium are highly associated with synovial fluid levels of APRIL in inflamed peripheral joints of rheumatoid arthritis. Rheumatol Int. 2009;29(7):801\u20136.","journal-title":"Rheumatol Int"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03426-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-024-03426-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03426-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T09:08:21Z","timestamp":1730365701000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-024-03426-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3426"],"URL":"https:\/\/doi.org\/10.1186\/s13075-024-03426-2","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]},"assertion":[{"value":"28 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Review Board of the First Affiliated Hospital of Nanchang University, with the ethics approval number IIT[2023] Clinical Ethics Review No. 011. It was conducted in accordance with the Declaration of Helsinki (as revised in 2013), and written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient provided consent for publication of the images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}